Jian-Bo Xian-Yu1, Jia-Fu Feng2, Yu-Chun Chen3, Yu-Wei Yang2. 1. Department of General Surgery, Mianyang Central Hospital Sichuan 621000, China. 2. Department of Laboratory Medicine, Mianyang Central Hospital Sichuan 621000, China. 3. Department of Pharmacy, Mianyang Central Hospital Sichuan 621000, China.
Abstract
OBJECTIVE: This study aimed to investigate the effects of simvastatin (SVS) and atorvastatin (AVS) on the biochemical and hematological markers in patients with risk of cardiovascular diseases. METHODS: One hundred and fifty outpatients were enrolled from the Department of Cardiology. Patients were treated with AVS or SVS. The lipids and hematological parameters were measured at baseline and after 4-week treatment, and the risk factors of cardiovascular diseases were recorded. RESULTS: After 4-week treatment, the lipids significantly changed. However, for hematological parameters, only mean platelet volume (MPV) significantly decreased after statins treatment (SVS: t = 68.748, P = 0.000; AVS: t = 39.472, P = 0.000), and the extent of decline was similar between SVS group and AVS group (t = 1.063, P = 0.289). There were no correlations between MPV and lipids. SVS and AVS had comparable effects on the lipid parameters after 4-week treatment, and there were no significant correlations of ΔMPV with the Δtotal cholesterol, Δhigh density lipoprotein-cholesterol, Δlow density lipoprotein-cholesterol, Δtriglyceride, Δapolipoproteint A1, Δapolipoproteint B and Δlipoproteint (a) after treatments (all P > 0.05). CONCLUSION: After statins treatment, the lipids significantly change; only MPV significantly decreases among hematological parameters, but it has no relationship with lipids reduction. The synthetic atorvastatin has similar effects to native simvastatin in the management of patients with risk for cardiovascular diseases.
OBJECTIVE: This study aimed to investigate the effects of simvastatin (SVS) and atorvastatin (AVS) on the biochemical and hematological markers in patients with risk of cardiovascular diseases. METHODS: One hundred and fifty outpatients were enrolled from the Department of Cardiology. Patients were treated with AVS or SVS. The lipids and hematological parameters were measured at baseline and after 4-week treatment, and the risk factors of cardiovascular diseases were recorded. RESULTS: After 4-week treatment, the lipids significantly changed. However, for hematological parameters, only mean platelet volume (MPV) significantly decreased after statins treatment (SVS: t = 68.748, P = 0.000; AVS: t = 39.472, P = 0.000), and the extent of decline was similar between SVS group and AVS group (t = 1.063, P = 0.289). There were no correlations between MPV and lipids. SVS and AVS had comparable effects on the lipid parameters after 4-week treatment, and there were no significant correlations of ΔMPV with the Δtotal cholesterol, Δhigh density lipoprotein-cholesterol, Δlow density lipoprotein-cholesterol, Δtriglyceride, Δapolipoproteint A1, Δapolipoproteint B and Δlipoproteint (a) after treatments (all P > 0.05). CONCLUSION: After statins treatment, the lipids significantly change; only MPV significantly decreases among hematological parameters, but it has no relationship with lipids reduction. The synthetic atorvastatin has similar effects to native simvastatin in the management of patients with risk for cardiovascular diseases.
Entities:
Keywords:
Statin; blood; lipid; mean platelet volume
Authors: Gregory G Westin; Ehrin J Armstrong; Heejung Bang; Khung-Keong Yeo; David Anderson; David L Dawson; William C Pevec; Ezra A Amsterdam; John R Laird Journal: J Am Coll Cardiol Date: 2013-12-04 Impact factor: 24.094
Authors: Ross J Simpson; James Signorovitch; Howard Birnbaum; Jasmina Ivanova; Cristina Connolly; Yohanne Kidolezi; Andreas Kuznik Journal: Mayo Clin Proc Date: 2009-12 Impact factor: 7.616
Authors: Lisiane Smiderle; Luciana O Lima; Mara Helena Hutz; Cézar Roberto Van der Sand; Luiz Carlos Van der Sand; Maria Elvira Wagner Ferreira; Renan Canibal Pires; Silvana Almeida; Marilu Fiegenbaum Journal: Arq Bras Cardiol Date: 2014-07 Impact factor: 2.000
Authors: Andrew W Gardner; Petar Alaupovic; Donald E Parker; Polly S Montgomery; Omar L Esponda; Ana I Casanegra Journal: Int J Vasc Med Date: 2013-09-11